IDenta Corp. (IDTA)

USD 0.45

(0.0%)

Long Term Debt Summary of IDenta Corp.

  • IDenta Corp.'s latest annual long term debt in 2023 was 428.17 Thousand USD , up 14.92% from previous year.
  • IDenta Corp.'s latest quarterly long term debt in 2024 Q1 was 694.7 Thousand USD , down -0.78% from previous quarter.
  • IDenta Corp. reported annual long term debt of 372.59 Thousand USD in 2022, down 0.0% from previous year.
  • IDenta Corp. reported annual long term debt of - USD in 2021, down 0.0% from previous year.
  • IDenta Corp. reported quarterly long term debt of 694.7 Thousand USD for 2024 Q1, down -0.78% from previous quarter.
  • IDenta Corp. reported quarterly long term debt of 428.17 Thousand USD for 2023 Q4, down 0.0% from previous quarter.

Annual Long Term Debt Chart of IDenta Corp. (2023 - 2014)

Historical Annual Long Term Debt of IDenta Corp. (2023 - 2014)

Year Long Term Debt Long Term Debt Growth
2023 428.17 Thousand USD 14.92%
2022 372.59 Thousand USD 0.0%
2021 - USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD -100.0%
2016 16.07 Thousand USD -76.52%
2015 68.45 Thousand USD 2.34%
2014 66.89 Thousand USD 0.0%

Peer Long Term Debt Comparison of IDenta Corp.

Name Long Term Debt Long Term Debt Difference
American Bio Medica Corporation 6000.00 USD -7036.267%
Arrayit Corporation - USD -Infinity%
Atlantic International Corp. 1.29 Million USD 67.0%
Biocept, Inc. 10.37 Million USD 95.873%
Bioqual, Inc. - USD -Infinity%
CardioGenics Holdings Inc - USD -Infinity%
DermTech, Inc. 51.3 Million USD 99.165%
Global WholeHealth Partners Corporation - USD -Infinity%
Hangzhou Tigermed Consulting Co., Ltd. 61.22 Million USD 99.301%
HTG Molecular Diagnostics, Inc. 546.32 Thousand USD 21.626%
iMD Companies, Inc. 1.1 Million USD 61.204%
Interpace Biosciences, Inc. 4.24 Million USD 89.909%
Integrative Health Technologies, Inc. - USD -Infinity%
InVitro International - USD -Infinity%
Lumos Diagnostics Holdings Limited - USD -Infinity%
Many Bright Ideas Technologies Inc. - USD -Infinity%
Medical Imaging Corp. 278 Thousand USD -54.02%
NovelStem International Corp. 3.32 Million USD 87.121%
Optigenex Inc. 4.42 Million USD 90.328%
PharmChem, Inc. - USD -Infinity%
Proteome Sciences plc 1.63 Million USD 73.748%
Response Genetics, Inc 4.91 Million USD 91.294%
Rennova Health, Inc. 359.19 Thousand USD -19.205%
RushNet, Inc. 4.25 Million USD 89.931%
ScreenPro Security Inc. 249.05 Thousand USD -71.924%
Stella Diagnostics Inc. 798.44 Thousand USD 46.373%
StageZero Life Sciences Ltd. 576.38 Thousand USD 25.713%
Todos Medical Ltd. 33 Million USD 98.703%